A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2015
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia; Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 03 May 2014 Results presented at the 33rd Annual Scientific Meeting of the American Pain Society.
- 03 May 2014 Results according to baseline antidepressant class presented at the 33rd Annual Scientific Meeting of the American Pain Society.
- 30 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History